Geode Capital Management »

Cue Biopharma shares owned by Geode Capital Management

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.5M 48k 31.56

More positions owned by Geode Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Inc-cl C Cap Stk Cl C (GOOG)
Micron Technology (MU)
Meta Platforms Inc-class A Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Berkshire Hathaway Inc-cl B Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Applied Materials (AMAT)

View all positions for Geode Capital Management

Top funds holding Cue Biopharma

Bleichroeder
Driehaus Capital Management
Vanguard Capital Management
Ikarian Capital
Polygon Management
Stempoint Capital
BlackRock
ADAR1 Capital Management
Lion Point Capital
Squadron Capital Management
Diadema Partners
Geode Capital Management
Belvedere Trading
Boothbay Fund Management
UBS Group

View all funds holding Cue Biopharma